絞り込み

16642

広告

3269件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Stability indicating RP-HPLC method development and validation for determination of 9 impurities in apixaban tablet dosage forms. Robustness study by Quality by Design approach.

Hospital Medicine Update: High-Impact Literature from March 2018 to April 2019.

Direct Oral Anticoagulant Use Following Transcatheter Aortic Valve Replacement: A Case Series.

Differences In Gastrointestinal Safety Profiles Among Novel Oral Anticoagulants: Evidence From A Network Meta-Analysis.

Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases.

Impact of direct oral anticoagulants off-label doses on clinical outcomes of atrial fibrillation patients: a systematic review.

Apixaban and Dalteparin in Active Malignancy Associated Venous Thromboembolism: The ADAM VTE Trial.

Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK.

Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant.

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study.

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017.

Atrial fibrillation in patients with end-stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation.

How minimally interrupted direct oral anticoagulants affect intraprocedural anticoagulation during atrial fibrillation ablation? Insights from a Japanese single-center retrospective study.

Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis.

Pulmonary embolism and thrombus in transit through patent foramen ovale.

Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation-A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation.

Direct-Acting Oral Anticoagulants and Their Reversal Agents-An Update.

Prothrombin Complex Concentrate before Urgent Surgery in Patients Treated with Rivaroxaban and Apixaban.

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and High Thromboembolic Risk. A Systematic Review.

Intracranial Hemorrhage following Lumbar Puncture in a Patient on Apixaban.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります